chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. On an unknown date the patients were vaccinated with improperly stored ZOSTAVAX (dose, lot #, expiration date and route were not reported). No adverse effects reported. It was unknown if patients sought medical attention. Additional information has been requested.
Experienced 40mins of numbness from both thighs to the lower abdominal area.   I am in health care and concern of GBS starting.   The numbness and sensation lasted for 40 mins then resolved itself.
pain in the left at muscle/This did happen with the first; This case was reported by a consumer via interactive digital media and described the occurrence of muscle pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th January 2020, the patient received the 1st dose of Shingrix. On 27th January 2020, less than a day after receiving Shingrix, the patient experienced muscle pain. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the muscle pain was unknown.   It was unknown if the reporter considered the muscle pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient received Shingrix and had pain in the left at muscle not relieved with Tylenol. For tolerances of 2nd dose, refer case US2020AMR015700, reported by same reporter for the same patient.
This spontaneous prospective pregnancy report as received from a consumer referred to her 15 years old daughter. The patient's history of previous pregnancies and live births was unknown. The patient had no pertinent medical history or drug reactions/allergies. The patient was vaccinated with dose 1, 0.5 ml GARDASIL during the middle of March 2012, before discovering that she was currently pregnant. No other co-suspects were reported. No concomitant medications were reported. The patient was exposed to GARDASIL during trimester 2. The patient did not seek medical attention. No treatment information was reported. On an unspecified date, pregnancy related  blood work laboratory was taken to determine risk for diabetes and sickle cell trait (results not provided). GARDASIL was discontinued and postponed until completed pregnancy. The outcome of patient was unknown. The event was not related to GARDASIL. Follow up information has been received from a other health professional on 26-FEB-2013. It was reported that the patient's demographic information was added and that at the time of this report the patient's age was 16 years old. Also, it was mentioned that GARDASIL (Lot number 1229AA, expiration date 12-NOV-2013, intramuscular route) was applied on 21-FEB-2012 (previously reported as 15-MAR-2012). Although, it was reported that the patient's last visit in office was on 20-APR-2012 for menstrual disorder, and at that time a pregnancy test (urine) was performed resulting positive. Patient was then referred to an Obstretical Gynecologist. Also, it was mentioned that on 20-APR-2012, the patient started to intake a prenatal therapy (30-0975, 200mg, daily, oral route). At the time of the report the pregnancy outcome was unknown. Additional information has been requested.
Right arm went numb a few minutes after injection. The numbness spread from upper arm to forearm within 15 minutes. It continued to spread to fingers and the upper arm muscle started to lock up or cramp. After the first hour no increase in numbness but no abatement. At present it continues. It is more prominent when arm is being utilized versus allowed to rest. It started around 9:20am and it is currently 3:48pm. Will go to an urgent care if the issue doesn't self resolve in next 24hours.
Patient's mother called 2/17/09 reporting, about 2 hours after receiving MENATRA injection c/o shooting down left arm and leg 2/16/09. Today 2/17/09 reports tiredness and out of breath. No fever or nausea. 2/23/09-records received for DOS 2/17/09-returned with C/O reaction to vaccine,  hours after receiving vaccine shooting pain down left arm and leg, difficulty sleeping, headache, shaky, SOB, fatigue, no energy. Left arm red, hot and swollen.
patient's titer for Varicella was negative; patient complained of pain at the injection site, on the left arm, after receiving M-M-R II; inadvertently received M-M-R II instead of Proquad; ptient received proquad on 07-DEC-2017; This spontaneous report was received from a Certified Medical Assistant and was refering to a 15 year old female patient. The patient's pertinent medical history included anxiety, depression, insomnia and migraines. The patient's concurrent conditions was not reported. The patient had no drug reactions or allergies.   On 07-DEC-2017, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD), (strength, dose number, frequency, route and anatomical location were not reported), lot number M048201, expiration date 05-JUN-2016 (reported as "05-JUN-2018"), as required immunization (Product administered to patient of inappropriate age).    On a n unknown date (reported as "on a recent unspecified date"), the patient's titers for varicella resulted as negative, showed no immunity (antibody test negative). Then, on 29-MAY-2019, the patient presented to the physician's office to obtain required immunizations, that had not be completed at that time. Then, on that date, the patient was inadvertently vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II), lot # R029513, expiration date 14-OCT-2020, 0.5 milliliter, once, subcutaneous in the left arm, diluted with sterile diluent, lot number R002518, expiration date 12-DEC-2019, as required immunization, instead of the required Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live(PROQUAD) (interchange of vaccine products). On the same date, the patient complained of pain at the injection site on the left arm.      On 31-MAY-2019, the patient was seen on the physician's office and the pain at the injection site was resolved. The patient did not received any treatment for the injection site pain.   At the time of reporting, the outcome of antibody test negative was unknown. The reporter did not assessed the causal relationship between the suspect therapies and all of the events.
She received the shots at 10:30 a.m and within and hour started severely crying, to the point where she would stop breathing and nothing could console her.   She continued doing so for 12 hours.  She had a rapid heart rate of 156 when sleeping and ran a fever.  At about 10:30 p.m after still hysterically crying she started tightening herself up (drawing in her legs, turning beat red and holding her breath).  When we reached the E.R. she then projectile vomited which she has never done.  She was given tylenol every 4 hours.  The E.R. had her on moniters and observed her for several hours.  She was then given tylenol every 4 hours for 24 more hours.
Received 1st dose COVID-19 Vaccine at 1705.  Ambulated to restroom and noted hives developed on torso and legs with heaviness in chest; denies difficulty breathing.  Received MD evaluation in ED.  Benadryl 50mg IV and Decadron 10mg IV.  Discharged home in stable condition.  Instructed NOT to receive 2nd COVID-19 Vaccine.  Home with Prednisone and Epi-pen PRN.
NauseaVomiting & HYPERtension Narrative: nausea and elevated blood pressure 141/91; reclined in chair for 10 minutes; nausea resolved and BP decreased to 127/82.
Nurse reported 35 minutes after vaccine administration the patient began to have nausea and vomited.
suspected vaccination failure/I have Shingles and I had already been vaccinated; shingles; very painful /burning pain on my body; burning feeling; I have more than a week of being inactive; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain, burning sensation and decreased activity. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles, pain, burning sensation and decreased activity were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain, burning sensation and decreased activity to be related to Shingles vaccine.  Additional details provided were as follows: The case was reported by patient herself. Age at vaccination was not reported. The patient received a dose of Shingles vaccine and at the time of reporting, the patient had shingles, it was very painful and the burning feeling was unbearable. She had more than a week of being inactive because of the burning pain on her body. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details available.
tired the next day; Pain in injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain in injection site arm) and FATIGUE (tired the next day) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A, 031L20A and 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Pain in injection site arm). On 21-Oct-2021, the patient experienced FATIGUE (tired the next day). At the time of the report, VACCINATION SITE PAIN (Pain in injection site arm) and FATIGUE (tired the next day) outcome was unknown.            No concomitant medication reported.  The patient received his third vaccine in his left arm shoulder deltoid muscle.  No treatment medication reported.   This case was linked to MOD-2022-543473, MOD-2022-543477 (Patient Link).
Sore left arm where shot was taken, Nausea, Headache, Symptoms lasted all Saturday.
My intent was to give patient both a 2nd dose Pfizer covid vaccine and a shingrix vaccine, but inadvertently gave her 2 Pfizer covid vaccines (followed by the Shingrix vaccine)
Pt is 17 y/o and was mistakenly given Moderna vaccine. Pt and parent were notified.
Patient passed out fell, hit head and had seizure like activity before coming to and proceeded to try and vomit. Laceration above right eye due to fall. Patient was monitored x 1 hour prior to being sent to the emergency department for further evaluation.
Wheezing and pneumonia began 4/22/08 at 8am.  6/13/08 Reviewed hospital medical records of 4/23-4/27/2008. FINAL DX: pneumonia; acute asthma exacerbation; dehydration. Records reveal patient experienced wheezing, coughing, low grade fever, reduced oral intake, decreased activity.  Failed outpatient treatment.  Admitted for O2, nebs, IV antibiotics & steroids.
2nd dose: Sore at site of injection left arm 5-6 hrs after injection. 6 AM body aches, chills and dizziness, symptoms are resolving at time of reporting 1 dose: only  soreness at site of injection few hrs
12/01/2022 I noticed I had a rash, like hives on my arms, legs and back. It continued to get worse until I could not stand it. I went to the doctor on 12/4/22. She gave me a prescription for prednisone. I have not been able to start the medication because I have not been able to fill the prescription. I have not recovered.
11/1/17: Spoke to Pt who states has arm pit pain, shoulder pain, and neck pain post vaccination. Left arm worse than right arm. Pt unable to sleep last night d/t pain on left arm. Pt states rcvd 2 vaccines in left arm. Pt took Motrin OTC (2 x200mg). Pt also took Tylenol but Tylenol does not help. Pt advised to take NSAID with food and no more than 800mg TID. Pt declined appt for tonight. Advised to use warm or cold compresses. Pt scheduled for 11/2/17 during evening clinic. Outcome: I called today since apt was canceled. Pt states no longer with pain or swelling. Pt states used warm compresses and is back to normal.
I had two Shingrix vaccinations.  One May 31,2018 and the second September 1, 2018.  Two weeks after the 2nd vaccination I had violent itching on my back not relieved with Benadryl or any prescription antihistamines. The itching soon turned to intermittent electrical shocks in my back and burning pain. I saw physicians here and even traveled to the other Clinics.  All believe my symptoms were a reaction to the vaccine.   I still continue to experience the burning pain as of 11/2/2020. which my neurologist believes is permanent nerve damage.  On a side note, it appears the vaccine did not stop me from getting a mild case of shingles fall of 2019.
son is 16 and just got the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose). On 31-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (son is 16 and just got the first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment information was provided.
sore arm; inability to lift arm; body ache; mild COVID-19-like symptoms; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (inability to lift arm), PAIN (body ache), COVID-19 (mild COVID-19-like symptoms) and FATIGUE (tiredness) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Seasonal allergy.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (inability to lift arm), PAIN (body ache), COVID-19 (mild COVID-19-like symptoms) and FATIGUE (tiredness). On 11-Mar-2021, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (inability to lift arm), PAIN (body ache), COVID-19 (mild COVID-19-like symptoms) and FATIGUE (tiredness) had resolved. On 12-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Nov-2020, SARS-CoV-2 test: positive (Positive) Positive. On 03-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment drugs were reported.
Information has been received from a registered nurse via a field employee concerning a female patient of unknown age who was also the nurse's sister. The patient's medical history, concurrent condition and concomitant therapy were not reported. On an unknown date years ago, the patient was vaccinated with the third doses of GARDASIL (lot #, expiration date, dose and route not reported) for routine military immunization. On an unknown date, the patient developed an unspecified "autoimmune induced vaccine reaction" after receiving the third dose of GARDASIL. The patient sought medical attention and was seen by multiple unspecified physician on multiple unspecified dates. The outcome of the unspecified "autoimmune induced vaccine reaction" was not resolved. Additional information has been requested.
Following the shot I experienced severe inflammation and pain in my left shoulder joint, and loss of range of motion in my shoulder. Symptoms persisted for several days and I eventually had to seek medical care and physical therapy. The is some speculation the vaccine was inject a little bit too high. Treatment with physical therapy has been effective for regaining my full range of motion and reducing pain.
Achy arm pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided as follows: The reporter reported for her friend. The age at vaccination was not reported. The patient had achy arm pain in her right arm after Shingrix injection. The reporter did not consent to follow-up. This case was 1 of the 3 cases reported by same reporter.
Following administration of DTaP-IPV vaccines patient developed agitation and difficulty breathing. She had been extremely combative during the immunization process. When she did not calm down quickly albuterol & O2 were administered by mask. Her O2 sats at room air were 85%. She developed pallor and was diaphoretic an Epi Pen Jr was injected in her thigh. EMS was called, by the time they arrived she was calming, cooperative and able to speak some. She was transported to ER and later admitted for 24 hours.   9/14/09 Hospital records received DOS 7/30/09. Assessment: Anaphylaxis. Patient presents with wheezing, difficulty breathing. Face flushed. Hypoxia. Diffuse body erythema.
Allergic reaction; This is a spontaneous report from a contactable consumer (patient) received through a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot Number: ER8735) as DOSE 1, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that after her first dose of the Pfizer vaccine, she experiences a severe allergic reaction on an unspecified date. she also mentioned that she already missed her second dose because she was afraid to take the second dose that is because of experience she had with the first dose, which is severe allergic reaction." she also wants to know how to go about this afterwards you know because everything is shutting down and there are lot of 'cases' that require vaccine cards (Further clarification was unknown)."Consumer was provided with the number of Pfizer Medical Information Department. When probed the permission to file safety report, consumer stated, "she thinks she will call them at another time because she on my Lunch break and she have to go back to work soon. The event outcome was unknown.  QR comment: Reporter type was not available over the call as the consumer was unwilling to answer further questions, hence reporter type was captured as consumer or non-healthcare professional by default.  Product details (Expiration date, NDC# and UPC#) treatment and other details could not be probed over the call as the consumer was not willing to share further information. Hence, Limited information was available over the call.
I had very severe lymph node swelling under my clavicle bone, armpit area and side of my breast. I also had exhaustion and fatigue for about 36-48 hours. It was the armpit pain I got concerned about. My doctor just recommended I take Tylenol which has helped. It is getting better daily.
pt recvd vax & exp general aches & pain, joint stiffness & malaise;
Patient stated she was sore from the shot (Vaccination date 01/17/2019). She followed up with her physicians, manufacturer and still not sure why her arm is still sore. There was redness and tenderness immediately following the vaccine which has subsided but the soreness is still lingering.
Temperature of 104F, vomiting, red and swollen arm at pneumovax site measuring 4" X 3 1/2". On 3/26/01, admitted to hospital for cellulitis.
Patietn reported red circle appeared on arm around injection site. It was about 2-3 inches in diameter. It produced heat. It was also firm to the touch.
constant tinnitus (still occurring), arm at the shoulder stiff and unusable (due to swelling/pain) for two weeks after the vaccine
A little sore arm after first shot; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little sore arm after first shot) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (A little sore arm after first shot). On 10-Jan-2021, PAIN IN EXTREMITY (A little sore arm after first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-407441, MOD-2021-407436 (Patient Link).
Severe Fever, Chills, Severe Fatigue, Headache, Joint pain
Pain edema erythema, lymphadenopathy in left axilla with pain, and Chills.
This spontaneous report was received from an elderly male patient in his 80s (reported as "north of 80) regarding himself. Patient's concurrent conditions, concomitant medications, historical conditions and historical drug allergies/reactions were not reported. On an unknown date in 2010, the patient was vaccinated with PNEUMOVAX 23 (strength, dose, frequency, route, lot number and expiry date not reported) for prevention of pneumococcal disease. On an unknown date in March 2017 (reported as "an year ago"), the patient had a pacemaker implantation (Cardiac pacemaker insertion) (medically significant). The outcome of pacemaker implantation insertion was not reported. Causality assessment was not provided. No further information was provided. A product quality complaint was not present. Upon internal review the event of pacemaker implantation was determined as medically significant.
Information has been received from a healthcare worker concerning an adult patient of unkonwn age and gender. No current or historical conditions were reported. On an unknown date between 18-FEB-2015 and 26-FEB-2015, the patient was inadvertently vaccinated with pediatric dose (unspecified in series) of RECOMBIVAX HB, 0.5 ml once, intramuscular (Accidental underdose). The administered dose could have been 1 of 2 lot numbers: lot# K008988 and expiration date 04-FEB-2016 or lot# K012469 and expiration 14-APR-2016. No adverse effects reported. Additional information has been requested.